TEAS RF New Application

INNOVUS PHARMA

Innovus Pharmaceuticals, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88597743
Filing Date: 08/29/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88597743
MARK INFORMATION
*MARK INNOVUS PHARMA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT INNOVUS PHARMA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Innovus Pharmaceuticals, Inc.
INTERNAL ADDRESS Legal
*STREET 8845 Rehco Road
*CITY San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
PHONE 858-249-7873
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Nevada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Dietary and nutritional supplements; Dietary and nutritional supplements for boosting testosterone and immune system, increasing muscle growth and endurance, preventing cachexia, increasing nitric oxide levels, increasing blood sugar levels, increasing blood flow, increasing sexual performance, increasing vision, weight loss, fat burning, prostate support, bladder control, joint support, nerve support, increasing mental cognition and memory, providing omega 3 oils.
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 09/05/2013
       FIRST USE IN COMMERCE DATE At least as early as 09/05/2013
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT17\IMAGEOUT 17\885\977\88597743\xml1\ RFA0003.JPG
        \\TICRS\EXPORT17\IMAGEOUT 17\885\977\88597743\xml1\ RFA0004.JPG
        \\TICRS\EXPORT17\IMAGEOUT 17\885\977\88597743\xml1\ RFA0005.JPG
       SPECIMEN DESCRIPTION The specimens consist of products sold and distributed by the Applicant.
ATTORNEY INFORMATION
NAME Randy Berholtz
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
INTERNAL ADDRESS Legal
STREET 8845 Rehco Road
CITY San Diego
STATE California
COUNTRY United States
ZIP/POSTAL CODE 92121
PHONE 858-249-7873
EMAIL ADDRESS rberholtz@innovuspharma.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Jake Siciliano
CORRESPONDENCE INFORMATION
NAME Randy Berholtz
INTERNAL ADDRESS Legal
STREET 8845 Rehco Road
CITY San Diego
STATE California
COUNTRY United States
ZIP/POSTAL CODE 92121
PHONE 858-249-7873
*EMAIL ADDRESS rberholtz@innovuspharma.com; jsiciliano@innovuspharma.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 275
*TOTAL FEE PAID 275
SIGNATURE INFORMATION
SIGNATURE /Randy Berholtz/
SIGNATORY'S NAME Randy Berholtz
SIGNATORY'S POSITION EVP Corporate Development
SIGNATORY'S PHONE NUMBER 858-249-7873
DATE SIGNED 08/29/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88597743
Filing Date: 08/29/2019

To the Commissioner for Trademarks:

MARK: INNOVUS PHARMA (Standard Characters, see mark)
The literal element of the mark consists of INNOVUS PHARMA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Innovus Pharmaceuticals, Inc., a corporation of Nevada, having an address of
      Legal
      8845 Rehco Road
      San Diego, California 92121
      United States
      858-249-7873(phone)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Dietary and nutritional supplements; Dietary and nutritional supplements for boosting testosterone and immune system, increasing muscle growth and endurance, preventing cachexia, increasing nitric oxide levels, increasing blood sugar levels, increasing blood flow, increasing sexual performance, increasing vision, weight loss, fat burning, prostate support, bladder control, joint support, nerve support, increasing mental cognition and memory, providing omega 3 oils.

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 09/05/2013, and first used in commerce at least as early as 09/05/2013, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) The specimens consist of products sold and distributed by the Applicant..
Specimen File1
Specimen File2
Specimen File3



The applicant hereby appoints Randy Berholtz. Other appointed attorneys are Jake Siciliano. Randy Berholtz, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Legal
      8845 Rehco Road
      San Diego, California 92121
      United States
      858-249-7873(phone)
      rberholtz@innovuspharma.com (authorized).

Randy Berholtz submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Randy Berholtz
      Legal
      8845 Rehco Road
      San Diego, California 92121
      858-249-7873(phone)
      rberholtz@innovuspharma.com; jsiciliano@innovuspharma.com (authorized).

Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Randy Berholtz/   Date: 08/29/2019
Signatory's Name: Randy Berholtz
Signatory's Position: EVP Corporate Development
Payment Sale Number: 88597743
Payment Accounting Date: 08/29/2019

Serial Number: 88597743
Internet Transmission Date: Thu Aug 29 12:19:37 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XX.XXX-2019082912193725
7807-88597743-610156ae4a038aed1ced1bf7c0
f6409ee4b38d44d6a1837ce3750ac289fd3d6d7-
CC-19360969-20190829120335714095

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed